Copyright Reports & Markets. All rights reserved.

Global Low Molecular Weight Heparin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Low Molecular Weight Heparin Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Enoxaparin
    • 1.3.3 Dalteparin
    • 1.3.4 Tinzaparin
    • 1.3.5 Fraxiparine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Low Molecular Weight Heparin Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Treatment of Venous Thromboembolism
    • 1.4.3 Complications of Pregnancy
    • 1.4.4 Cardioversion of Atrial Fibrillation/Flutter
    • 1.4.5 Others
  • 1.5 Global Low Molecular Weight Heparin Market Size & Forecast
    • 1.5.1 Global Low Molecular Weight Heparin Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Low Molecular Weight Heparin Sales Quantity (2020-2031)
    • 1.5.3 Global Low Molecular Weight Heparin Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Aspen
    • 2.1.1 Aspen Details
    • 2.1.2 Aspen Major Business
    • 2.1.3 Aspen Low Molecular Weight Heparin Product and Services
    • 2.1.4 Aspen Low Molecular Weight Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Aspen Recent Developments/Updates
  • 2.2 Sanofi-aventis
    • 2.2.1 Sanofi-aventis Details
    • 2.2.2 Sanofi-aventis Major Business
    • 2.2.3 Sanofi-aventis Low Molecular Weight Heparin Product and Services
    • 2.2.4 Sanofi-aventis Low Molecular Weight Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Sanofi-aventis Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Low Molecular Weight Heparin Product and Services
    • 2.3.4 Pfizer Low Molecular Weight Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 Opocrin
    • 2.4.1 Opocrin Details
    • 2.4.2 Opocrin Major Business
    • 2.4.3 Opocrin Low Molecular Weight Heparin Product and Services
    • 2.4.4 Opocrin Low Molecular Weight Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Opocrin Recent Developments/Updates
  • 2.5 CSBIO
    • 2.5.1 CSBIO Details
    • 2.5.2 CSBIO Major Business
    • 2.5.3 CSBIO Low Molecular Weight Heparin Product and Services
    • 2.5.4 CSBIO Low Molecular Weight Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 CSBIO Recent Developments/Updates
  • 2.6 Dongying Tiandong Pharmaceutical
    • 2.6.1 Dongying Tiandong Pharmaceutical Details
    • 2.6.2 Dongying Tiandong Pharmaceutical Major Business
    • 2.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product and Services
    • 2.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
  • 2.7 Changzhou Qianhong Bio-pharma
    • 2.7.1 Changzhou Qianhong Bio-pharma Details
    • 2.7.2 Changzhou Qianhong Bio-pharma Major Business
    • 2.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product and Services
    • 2.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
  • 2.8 Techdow
    • 2.8.1 Techdow Details
    • 2.8.2 Techdow Major Business
    • 2.8.3 Techdow Low Molecular Weight Heparin Product and Services
    • 2.8.4 Techdow Low Molecular Weight Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Techdow Recent Developments/Updates
  • 2.9 Yantai Dongcheng Pharmaceutical Group
    • 2.9.1 Yantai Dongcheng Pharmaceutical Group Details
    • 2.9.2 Yantai Dongcheng Pharmaceutical Group Major Business
    • 2.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product and Services
    • 2.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Low Molecular Weight Heparin by Manufacturer

  • 3.1 Global Low Molecular Weight Heparin Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Low Molecular Weight Heparin Revenue by Manufacturer (2020-2025)
  • 3.3 Global Low Molecular Weight Heparin Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Low Molecular Weight Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Low Molecular Weight Heparin Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Low Molecular Weight Heparin Manufacturer Market Share in 2024
  • 3.5 Low Molecular Weight Heparin Market: Overall Company Footprint Analysis
    • 3.5.1 Low Molecular Weight Heparin Market: Region Footprint
    • 3.5.2 Low Molecular Weight Heparin Market: Company Product Type Footprint
    • 3.5.3 Low Molecular Weight Heparin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Low Molecular Weight Heparin Market Size by Region
    • 4.1.1 Global Low Molecular Weight Heparin Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Low Molecular Weight Heparin Consumption Value by Region (2020-2031)
    • 4.1.3 Global Low Molecular Weight Heparin Average Price by Region (2020-2031)
  • 4.2 North America Low Molecular Weight Heparin Consumption Value (2020-2031)
  • 4.3 Europe Low Molecular Weight Heparin Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Low Molecular Weight Heparin Consumption Value (2020-2031)
  • 4.5 South America Low Molecular Weight Heparin Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Low Molecular Weight Heparin Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Low Molecular Weight Heparin Sales Quantity by Type (2020-2031)
  • 5.2 Global Low Molecular Weight Heparin Consumption Value by Type (2020-2031)
  • 5.3 Global Low Molecular Weight Heparin Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Low Molecular Weight Heparin Sales Quantity by Application (2020-2031)
  • 6.2 Global Low Molecular Weight Heparin Consumption Value by Application (2020-2031)
  • 6.3 Global Low Molecular Weight Heparin Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Low Molecular Weight Heparin Sales Quantity by Type (2020-2031)
  • 7.2 North America Low Molecular Weight Heparin Sales Quantity by Application (2020-2031)
  • 7.3 North America Low Molecular Weight Heparin Market Size by Country
    • 7.3.1 North America Low Molecular Weight Heparin Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Low Molecular Weight Heparin Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Low Molecular Weight Heparin Sales Quantity by Type (2020-2031)
  • 8.2 Europe Low Molecular Weight Heparin Sales Quantity by Application (2020-2031)
  • 8.3 Europe Low Molecular Weight Heparin Market Size by Country
    • 8.3.1 Europe Low Molecular Weight Heparin Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Low Molecular Weight Heparin Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Low Molecular Weight Heparin Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Low Molecular Weight Heparin Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Low Molecular Weight Heparin Market Size by Region
    • 9.3.1 Asia-Pacific Low Molecular Weight Heparin Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Low Molecular Weight Heparin Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Low Molecular Weight Heparin Sales Quantity by Type (2020-2031)
  • 10.2 South America Low Molecular Weight Heparin Sales Quantity by Application (2020-2031)
  • 10.3 South America Low Molecular Weight Heparin Market Size by Country
    • 10.3.1 South America Low Molecular Weight Heparin Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Low Molecular Weight Heparin Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Low Molecular Weight Heparin Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Low Molecular Weight Heparin Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Low Molecular Weight Heparin Market Size by Country
    • 11.3.1 Middle East & Africa Low Molecular Weight Heparin Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Low Molecular Weight Heparin Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Low Molecular Weight Heparin Market Drivers
  • 12.2 Low Molecular Weight Heparin Market Restraints
  • 12.3 Low Molecular Weight Heparin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Low Molecular Weight Heparin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Low Molecular Weight Heparin
  • 13.3 Low Molecular Weight Heparin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Low Molecular Weight Heparin Typical Distributors
  • 14.3 Low Molecular Weight Heparin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 387 million in 2024 and is forecast to a readjusted size of USD 552 million by 2031 with a CAGR of 5.3% during review period.
    Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
    Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.
    Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 35%.
    This report is a detailed and comprehensive analysis for global Low Molecular Weight Heparin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Low Molecular Weight Heparin market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2020-2031
    Global Low Molecular Weight Heparin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2020-2031
    Global Low Molecular Weight Heparin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2020-2031
    Global Low Molecular Weight Heparin market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Low Molecular Weight Heparin
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Low Molecular Weight Heparin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Low Molecular Weight Heparin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Enoxaparin
    Dalteparin
    Tinzaparin
    Fraxiparine
    Market segment by Application
    Treatment of Venous Thromboembolism
    Complications of Pregnancy
    Cardioversion of Atrial Fibrillation/Flutter
    Others
    Major players covered
    Aspen
    Sanofi-aventis
    Pfizer
    Opocrin
    CSBIO
    Dongying Tiandong Pharmaceutical
    Changzhou Qianhong Bio-pharma
    Techdow
    Yantai Dongcheng Pharmaceutical Group
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Low Molecular Weight Heparin product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Low Molecular Weight Heparin, with price, sales quantity, revenue, and global market share of Low Molecular Weight Heparin from 2020 to 2025.
    Chapter 3, the Low Molecular Weight Heparin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Low Molecular Weight Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Low Molecular Weight Heparin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Low Molecular Weight Heparin.
    Chapter 14 and 15, to describe Low Molecular Weight Heparin sales channel, distributors, customers, research findings and conclusion.

    Buy now